The 2021 ASCO Annual Meeting will be held virtually on June 4-8.
Found below is the list of kidney cancer-related abstracts that will be featured at ASCO21. Don’t miss these highlights recommended by the UROONCO Editorial Board!
Pembrolizumab versus placebo as post nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase 3. KEYNOTE-564 study (LBA5)
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.I agreeRead More